SCHEMBL5548

SCHEMBL5548

CC(C)[C@]1(O)CC[C@]2(CCN(c3ccc(C(C)(C)C)cc3)C2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.36
CYP2C19 P33261 4/20 0.36
HIF1A Q16665 3/20 0.36
ALDH1A1 P00352 4/20 0.36
USP2 O75604 3/20 0.36
CYP1A2 P05177 3/20 0.36
CYP2C9 P11712 3/20 0.36
HSD17B10 Q99714 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ALOX15 P16050 2/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD11B1 P28845 3/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
OPRL1 P41146 1/20 0.35
MAPK1 P28482 4/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617 0.88 CYP3A4 (0.42) CYP3A4CYP2C19HIF1AUSP2CYP1A2
SCHEMBL4615 0.81 HSD11B1 (0.42) CYP3A4CYP2C19HIF1AALDH1A1USP2
SCHEMBL5391 0.80 CYP3A4 (0.35) CYP3A4CYP2C19HIF1AALDH1A1USP2
SCHEMBL5569 0.80 USP2 (0.41) CYP3A4CYP2C19HIF1AALDH1A1USP2
SCHEMBL5301 0.80 EPHX2 (0.42)
SCHEMBL11842 0.80 LIPE (0.35) CYP3A4CYP2C19HIF1AALDH1A1USP2
SCHEMBL5651 0.79 LIPE (0.38) CYP3A4CYP2C19HIF1AALDH1A1USP2
SCHEMBL5989 0.78 CYP3A4 (0.40) CYP3A4CYP2C19HIF1AALDH1A1USP2
SCHEMBL5214 0.74 S1PR1 (0.40) CYP3A4CYP2C19HIF1AALDH1A1USP2
SCHEMBL24124025 0.72 HSD11B1 (0.41) CYP2C19ALDH1A1USP2CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP claimed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO claimed